{"id":"11452d14-11b8-4a55-a1ce-6a16e20e1313","modelId":"e255b803-6098-49ab-9a88-2c25b513cb32","versionId":null,"locationId":"aad1b278-b2b9-403b-bb76-236326bd3181","operatorId":null,"ownerId":null,"slug":"neuralink-miami-project-fl","status":"operational","firstSeen":"2025-04-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":null,"sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://news.med.miami.edu/paralyzed-veteran-surgically-implanted-with-neuralink-device-at-the-miami-project-to-cure-paralysis/","name":"University of Miami","title":"Paralyzed Veteran Surgically Implanted with Neuralink Device"}],"notes":"University of Miami Miller School of Medicine implanted 5th PRIME participant — a paralyzed US military veteran. Patient controls computer and smartphone with thoughts.","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-14T13:44:09.810Z","updatedAt":"2026-08-14T13:44:10.206Z","model":{"id":"e255b803-6098-49ab-9a88-2c25b513cb32","companyId":"01eea241-8b2a-46e5-bdcd-e09761c61c28","modelName":"Neuralink N1 Implant","slug":"neuralink-n1-implant","description":"The Neuralink N1 Implant is a brain-computer interface chip with ultra-fine, flexible threads that is surgically placed by the R1 Robot into a region of the brain that controls movement intention. It enables people with paralysis to control computers and external devices with their thoughts. First implanted in human patient Noland Arbaugh in January 2024 as part of the PRIME Study.","formFactor":"wearable","industryVertical":null,"environment":null,"maturityStage":"pilot","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://neuralink.com/updates/first-clinical-trial-open-for-recruitment/","title":"Neuralink's First-in-Human Clinical Trial","sourceName":"Neuralink"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Founder","value":"Elon Musk"},{"label":"Total funding","value":"approximately $1.85B ($650M Series E at $9.6B valuation)"},{"label":"Products","value":"N1 Implant (brain chip), R1 Robot (surgical robot)"},{"label":"Clinical trial","value":"PRIME Study (NCT06429735, first-in-human)"},{"label":"FDA","value":"Breakthrough Device designation"},{"label":"First patient","value":"Noland Arbaugh (January 2024)"},{"label":"Patients","value":"approximately 12 implanted by late 2025"}],"createdAt":"2026-07-06T07:12:20.268Z","updatedAt":"2026-07-08T20:02:15.945Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"01eea241-8b2a-46e5-bdcd-e09761c61c28","name":"Neuralink","slug":"neuralink","description":"Neuralink is a brain-computer interface (BCI) company founded by Elon Musk in 2016, developing implantable brain chips that enable people with paralysis to control computers and devices with their thoughts. The company's N1 Implant is surgically placed by the R1 Robot, and its PRIME Study began first-in-human trials in January 2024 with patient Noland Arbaugh. Neuralink received FDA Breakthrough Device designation, implanted devices in approximately a dozen patients by late 2025, and raised approximately $1.85B in total funding including a $650M Series E at a $9.6B valuation.","status":null,"founded":2016,"hq":"Fremont, CA, USA","hqLat":37.5482697,"hqLng":-121.988571,"hqGeocodedAt":"2026-08-05T14:40:55.605Z","hqAddress":null,"hqPrecision":null,"website":"neuralink.com","fundingTotal":"650000000","type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://neuralink.com/","title":"Neuralink - Pioneering Brain Computer Interfaces","sourceName":"Neuralink"}],"keyFacts":[{"label":"Founder","value":"Elon Musk"},{"label":"Total funding","value":"approximately $1.85B ($650M Series E at $9.6B valuation)"},{"label":"Products","value":"N1 Implant (brain chip), R1 Robot (surgical robot)"},{"label":"Clinical trial","value":"PRIME Study (NCT06429735, first-in-human)"},{"label":"FDA","value":"Breakthrough Device designation"},{"label":"First patient","value":"Noland Arbaugh (January 2024)"},{"label":"Patients","value":"21 trial patients implanted as of early 2026 (company-reported)"},{"label":"Secondary market valuation","value":"USD 29-42 billion (July 2026, Caplight data; Business Insider)"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-06T07:11:01.869Z","updatedAt":"2026-08-05T14:47:21.398Z"}},"version":null,"location":{"id":"aad1b278-b2b9-403b-bb76-236326bd3181","name":"Baptist Hospital of Miami","slug":"miami-florida-usa","kind":"hospital","parentLocationId":null,"region":null,"lat":null,"lng":null,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-08T22:32:42.793Z","updatedAt":"2026-08-09T04:26:19.821Z"},"operator":null,"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/neuralink-miami-project-fl","url":"https://registry.deploy.report/deployments/neuralink-miami-project-fl","name":"Neuralink N1 Implant at Baptist Hospital of Miami","identifier":"11452d14-11b8-4a55-a1ce-6a16e20e1313","startDate":"2025-04-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/miami-florida-usa","name":"Baptist Hospital of Miami"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/neuralink","name":"Neuralink"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/neuralink-n1-implant","name":"Neuralink N1 Implant"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"pilot","lifecycle_state":"active","architectural_position":{"cohort":"wearable","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}